Global Market Analysis: Progressive Familial Intrahepatic Cholestasis Type 2 Treatment Landscape
Progressive Familial Intrahepatic Cholestasis Type 2 Treatment Market: An Overview Progressive Familial Intrahepatic Cholestasis Type 2 (PFIC2) is a rare genetic liver disorder characterized by impaired bile flow due to mutations in the ATP8B1 gene. This condition leads to the accumulation of bile acids in the liver, causing progressive liver damage, cholestasis, and...
0 Comments 0 Shares 95 Views 0 Reviews
Sponsored